UROGEN WELL D-ONE : Evaluation of a Novel Diagnostic for Sexually Transmitted Bacterial Infections

Plain-language summary

This study evaluates a new diagnostic test for sexually transmitted bacterial infections; no treatment was given during the study. It enrolled sexually active participants who were able to give informed consent. The study was a non-phased evaluation study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Cwm Taf University Health Board (NHS)

Intervention

No intervention. This study was an evalution with no intervention.

Start date

9/5/2018

Estimated completion

9/5/2019

Countries

United Kingdom

Related genes

Locations

• Llantrisant, United Kingdom

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

Participants must be sexually active. Participants will only be able to consent to this study if they have read and understood the Participant Information Sheet and been consented by a research nurse.

Exclusion Criteria:

Patients aged under 16 years. Patients who are victims of sexual assault Patients who are not sexually active Patients who are deemed unable to give informed consent.